Bridgebio Oncology Therapeutics, Inc. (BBOT)

2.62 -0.08 (-2.96%) USD  |  NASDAQ  |  Oct 30, 16:00
2.64 +0.02 (+0.76%) After-Hours: 20:00
More

Bridgebio Oncology Therapeutics EV to CFO

EV to CFO Chart

View EV to CFO for BBOT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to CFO Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
Date Value
December 31, 2025 --
September 30, 2025 --

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Korsana Biosciences, Inc. Upgrade
IRulya Therapeutics, Inc. Upgrade
PepGen Inc. Upgrade
Q32 Bio, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade

EV to CFO Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade